These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 28270102)

  • 1. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S; Ohama Y; Okazaki M; Nukui Y; Moriya K
    BMC Infect Dis; 2017 Mar; 17(1):197. PubMed ID: 28270102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH; Arslan N; Esen N; Özkütük AA
    Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
    Aono A; Morimoto K; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
    J Infect Chemother; 2019 Feb; 25(2):117-123. PubMed ID: 30447882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002.
    Huang TS; Lee SS; Hsueh PR; Tsai HC; Chen YS; Wann SR; Leu HS; Ko WC; Yan JJ; Yuan SZ; Chang FY; Lu JJ; Wang JH; Wang HK; Liu YC
    J Formos Med Assoc; 2008 Apr; 107(4):281-7. PubMed ID: 18445541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
    Yang SC; Hsueh PR; Lai HC; Teng LJ; Huang LM; Chen JM; Wang SK; Shie DC; Ho SW; Luh KT
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
    Hershko Y; Adler A
    Microb Drug Resist; 2023 Jul; 29(7):302-308. PubMed ID: 37219996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview.
    Kumar C; Shrivastava K; Singh A; Chauhan V; Varma-Basil M
    Int J Mycobacteriol; 2021; 10(3):293-300. PubMed ID: 34494569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance in
    Jayasingam SD; Zin T; Ngeow YF
    Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
    Kamada K; Yoshida A; Iguchi S; Arai Y; Uzawa Y; Konno S; Shimojima M; Kikuchi K
    Sci Rep; 2021 Jun; 11(1):12208. PubMed ID: 34108590
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of rapidly growing mycobacterial infections.
    Kasperbauer SH; De Groote MA
    Clin Chest Med; 2015 Mar; 36(1):67-78. PubMed ID: 25676520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China.
    Pang H; Li G; Zhao X; Liu H; Wan K; Yu P
    Biomed Res Int; 2015; 2015():419392. PubMed ID: 26351633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility.
    Brown-Elliott BA; Hanson K; Vasireddy S; Iakhiaeva E; Nash KA; Vasireddy R; Parodi N; Smith T; Gee M; Strong A; Barker A; Cohen S; Muir H; Slechta ES; Wallace RJ
    J Clin Microbiol; 2015 Mar; 53(3):875-8. PubMed ID: 25568437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ; Brown-Elliott BA; Crist CJ; Mann L; Wilson RW
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug susceptibility testing of rapidly growing mycobacteria in extrapulmonary tuberculosis.
    Gole GV; Set R; Khan N; Shastri J
    Indian J Tuberc; 2016 Apr; 63(2):119-22. PubMed ID: 27451822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
    Cavusoglu C; Gurpinar T; Ecemis T
    New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.